Digilab BioVision (www.peptidomics.com) inked a licensing agreement with GenWay Biotech (www.genwaybio.com). Under the terms of the agreement, Digilab’s location in Hannover, Germany, will become the European Seppro® Center. This agreement broadens Digilab’s portfolio of preanalytical products and services by offering GenWay’s Seppro IgY technology. Seppro IgY selectively partitions the 12 most abundant proteins from human serum or plasma.

Next articleUMMZ Periodical Cicada Page